We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$921M
AUM Growth
-$85.5M
Cap. Flow
-$110M
Cap. Flow %
-11.98%
Top 10 Hldgs %
14.09%
Holding
5,143
New
1,384
Increased
1,284
Reduced
1,171
Closed
1,233

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$11.2M
2
XOM icon
ExxonMobil
XOM
+$10.8M
3
AAPL icon
Apple
AAPL
+$10.8M
4
IBB icon
iShares Biotechnology ETF
IBB
+$10.2M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$8.12M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$265M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$98.3M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$32.7M
4
VNQ icon
Vanguard Real Estate ETF
VNQ
+$18.2M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$14.9M

Sector Composition

Rank Sector Weight
1 Financials 13.75%
2 Technology 8.29%
3 Industrials 7.33%
4 Healthcare 6.94%
5 Consumer Discretionary 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GARS
3326
DELISTED
Garrison Capital Inc.
GARS
$3K ﹤0.01%
293
-321
-52% -$3.04K
INWK
3327
DELISTED
InnerWorkings, Inc.
INWK
$3K ﹤0.01%
+297
New +$2.75K
MNTA
3328
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$3K ﹤0.01%
177
+50
+39% +$660
GSB
3329
DELISTED
GlobalSCAPE, Inc.
GSB
$3K ﹤0.01%
849
-1,320
-61% -$4.93K
BCTF
3330
DELISTED
Bancorp 34, Inc. Common Stock
BCTF
$3K ﹤0.01%
+203
New +$2.54K
DTO
3331
DELISTED
DB Crude Oil Double Short Exchange Traded Notes due June 1, 2038
DTO
$3K ﹤0.01%
+29
New +$3.48K
FOMX
3332
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$3K ﹤0.01%
+273
New +$2.57K
LTS
3333
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$3K ﹤0.01%
+1,158
New +$2.69K
FCSC
3334
DELISTED
Fibrocell Science Inc.
FCSC
$3K ﹤0.01%
292
-677
-70% -$7.27K
SSFN
3335
DELISTED
Stewardship Financial Corp
SSFN
$3K ﹤0.01%
321
-393
-55% -$3.32K
NVLN
3336
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$3K ﹤0.01%
+428
New +$3.79K
TRK
3337
DELISTED
Speedway Motorsports, Inc.
TRK
$3K ﹤0.01%
120
-180
-60% -$3.53K
BRSS
3338
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
$3K ﹤0.01%
+100
New +$3.02K
BLMT
3339
DELISTED
BSB Bancorp, Inc.
BLMT
$3K ﹤0.01%
95
+9
+10% +$235
AHL
3340
DELISTED
ASPEN Insurance Holding Limited
AHL
$3K ﹤0.01%
58
-2,798
-98% -$143K
FBR
3341
DELISTED
Fibria Celulose Sa
FBR
$3K ﹤0.01%
280
-10,145
-97% -$85.4K
EEP
3342
DELISTED
Enbridge Energy Partners
EEP
$3K ﹤0.01%
+110
New +$2.68K
LDF
3343
DELISTED
Latin American Discovery Fund
LDF
$3K ﹤0.01%
+351
New +$3.45K
EDGW
3344
DELISTED
Edgewater Technology Inc
EDGW
$3K ﹤0.01%
360
-72
-17% -$548
SRCLP
3345
DELISTED
Stericycle, Inc
SRCLP
$3K ﹤0.01%
+45
New +$2.85K
VCO
3346
DELISTED
Vina Concha Y Toro 50 Shrs
VCO
$3K ﹤0.01%
+100
New +$3.37K
ZAIS
3347
DELISTED
ZAIS Group Holdings, Inc.
ZAIS
$3K ﹤0.01%
1,752
-1,586
-48% -$2.64K
FOGO
3348
DELISTED
Fogo de Chao, Inc. Common Stock
FOGO
$3K ﹤0.01%
199
-963
-83% -$12.4K
GNCMA
3349
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
$3K ﹤0.01%
136
-1,210
-90% -$20K
SBCP
3350
DELISTED
Sunshine Bancorp, Inc
SBCP
$3K ﹤0.01%
+149
New +$2.34K
132 133
134
135 136

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2016 Portfolio in Review

As of Q4 2016, Tower Research Capital (TRC) held 5,143 positions worth $921M, down 8.5% from $1.01B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) withdrew a net $110M in Q4 2016, closing 1,233 positions and reducing 1,171 holdings. Its most notable exit was Vanguard Real Estate ETF, an estimated $18.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 3.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Biotechnology ETF worth $9.93M.

  • Tower Research Capital (TRC)'s largest Q4 2016 buy was iShares Biotechnology ETF: 112,296 shares worth $9.93M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2016, an estimated $11.2M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $265M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q4 2016, selling an estimated $18.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $921M portfolio in Q4 2016.
  • Tower Research Capital (TRC) opened 1,384 new positions and closed 1,233 in Q4 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 8.5% quarter-over-quarter to $921M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.